NASDAQ: LWAYLifeway Foods Inc Stock
$23.68-0.07 (-0.29%)
Updated Apr 30, 2025
LWAY Price
$23.68
Fair Value Price
$18.92
Market Cap
$360.01M
52 Week Low
$10.06
52 Week High
$28.61
P/E
38.82x
P/B
5.01x
P/S
1.96x
PEG
0.64x
Dividend Yield
N/A
Revenue
$186.82M
Earnings
$9.03M
Gross Margin
26%
Operating Margin
7.53%
Profit Margin
4.8%
Debt to Equity
0.26
Operating Cash Flow
$13M
Beta
0.78
Next Earnings
May 12, 2025
Ex-Dividend
N/A
Next Dividend
N/A
LWAY Overview
Lifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types, including low fat, non-fat, whole milk, protein, and BioKefir. The company also offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; cupped kefir and Icelandic Skyr, a line of strained kefir and yogurt products; and frozen kefir in soft serve and pint-size containers. It sells its products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers primarily through direct sales force, brokers, and distributors. The company was founded in 1986 and is based in Morton Grove, Illinois.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine LWAY's potential to beat the market
- LWAY doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Food
Industry Rating
B
LWAY
RankedUnranked of 49
RankedUnranked of 49
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.37 | A | |
| $7.20 | A | |
| $12.32 | A |
Be the first to know about important LWAY news, forecast changes, insider trades & much more!
LWAY News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how LWAY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
LWAY ($23.68) is overvalued by 25.13% relative to our estimate of its Fair Value price of $18.92 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
LWAY ($23.68) is not significantly undervalued (25.13%) relative to our estimate of its Fair Value price of $18.92 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
LWAY ($23.68) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more LWAY due diligence checks available for Premium users.
Valuation
LWAY fair value
Fair Value of LWAY stock based on Discounted Cash Flow (DCF)
Price
$23.68
Fair Value
$18.92
Overvalued by
25.13%
LWAY ($23.68) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
LWAY ($23.68) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
LWAY ($23.68) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
LWAY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
38.82x
Industry
15.75x
Market
29.18x
LWAY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
LWAY is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
LWAY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.01x
Industry
1.93x
LWAY is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
LWAY price to earnings growth (PEG)
For valuing profitable companies with growth potential
LWAY is good value based... subscribe to Premium to read more.
PEG Value Valuation
LWAY's financial health
Profit margin
Revenue
$46.9M
Net Income
-$160.0k
Profit Margin
-0.3%
LWAY's Earnings (EBIT) of $14.07M... subscribe to Premium to read more.
Interest Coverage Financials
LWAY's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$90.5M
Liabilities
$18.6M
Debt to equity
0.26
LWAY's short-term assets ($43.61M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LWAY's short-term assets ($43.61M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LWAY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
LWAY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.6M
Investing
-$1.3M
Financing
$0.0
LWAY's operating cash flow ($12.96M)... subscribe to Premium to read more.
Debt Coverage Financials
LWAY vs Food Stocks
Lifeway Foods Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.